3-Iodo-6-methylimidazo[1,2-a]pyridine, 95.0%, 5g

4-Methyl-3-oxo-3,4-dihydro-quinoxaline-2-carboxylic acid, 95.0%, 2g

1-(3-Nitrophenyl)-piperazine hydrochloride, 95.0%, 25g

(5S,8S,10aR)-3-((Benzyloxy)carbonyl)-5-((tert-butoxycarbonyl)amino)-6-oxodecahydropyrrolo[1,2-a][1,5]diazocine-8-carboxylic acid, 97%, 1g

(R)-N-((S)-3,3-Dimethyl-1-(methylamino)-1-oxobutan-2-yl)-2-((S)-1-(N-hydroxyformamido)ethyl)-5-phenylpentanamide, 95%, 10mg

[(2,3-dichlorophenyl)methyl](prop-2-en-1-yl)amine hydrochloride, 95.0%, 10g

Benzenemethanesulfonamide, N-[2-(dimethylamino)ethyl]-3-[[4-[(2-methyl-1H-indol-5-yl)oxy]-2-pyrimidinyl]amino]-, 10mg

Quinoxaline-2-carboxamide, 95.0%, 250mg

6-Bromo-7-fluoroisobenzofuran-1(3H)-one, 98%, 250mg

tert-Butyl bis(2-bromoethyl)carbamate, 95.0%, 5g

Coloring container in accordance with Coplin with screw cap 6 pieces

(R)-1-m-Tolylethanamine, 95.0%, 1g

2,4-Diphenylpyridine, 95.0%, 250mg